Hostname: page-component-745bb68f8f-lrblm Total loading time: 0 Render date: 2025-02-06T06:20:21.099Z Has data issue: false hasContentIssue false

Changes in the chemical and in-vitro antihypertensive properties of sweet whey obtained from miniature fresh, Chanco and Gouda-style model cheeses

Published online by Cambridge University Press:  11 November 2020

Josemaría Godoy
Affiliation:
Departamento de Ciencias Animales, Facultad de Agronomía e Ingeniería Forestal, Pontificia Universidad Católica de Chile, Santiago, Chile
Marie Peslerbes
Affiliation:
Departamento de Ciencias Animales, Facultad de Agronomía e Ingeniería Forestal, Pontificia Universidad Católica de Chile, Santiago, Chile
Stefanie Vyhmeister
Affiliation:
Departamento de Ciencias Animales, Facultad de Agronomía e Ingeniería Forestal, Pontificia Universidad Católica de Chile, Santiago, Chile
Einar Vargas-Bello-Pérez
Affiliation:
Departamento de Ciencias Animales, Facultad de Agronomía e Ingeniería Forestal, Pontificia Universidad Católica de Chile, Santiago, Chile Department of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Grønnegårdsvej 3, DK-1870, Frederiksberg C, Denmark
María Angélica Fellenberg
Affiliation:
Departamento de Ciencias Animales, Facultad de Agronomía e Ingeniería Forestal, Pontificia Universidad Católica de Chile, Santiago, Chile
Rodrigo A. Ibáñez*
Affiliation:
Departamento de Ciencias Animales, Facultad de Agronomía e Ingeniería Forestal, Pontificia Universidad Católica de Chile, Santiago, Chile Center for Dairy Research, University of Wisconsin-Madison, Madison, WI53706, USA
*
Author for correspondence: Rodrigo A. Ibáñez, Email: ribanez@cdr.wisc.edu
Rights & Permissions [Opens in a new window]

Abstract

This Technical Research Communication evaluated the influence of various cheese manufacture methods on the composition and in vitro antihypertensive activity of sweet whey samples obtained from miniature models for fresh, Chanco and Gouda-style cheese processing using bulk-tank milks throughout a year. Raw milks from morning milking were standardized, pasteurized and used to obtain sweet whey using cheesemaking protocols for each variety on 200 g scale, as well the use of whey dilution at levels of 0, 15, 30 and 45% in Chanco and Gouda-style making. The composition of sweet whey obtained within each cheesemaking variety was similar among different timepoints of the year (P > 0.05), which was attributed to similar composition of milks and the use standardized cheesemaking protocols used for this study. As expected, the use of whey dilution led to sweet whey samples with reduced levels of total solids (P < 0.05), but they exhibited an improvement of the in vitro antihypertensive properties, which may be attributed to the formation of low-molecular weight bioactive peptides due to increased cheese making times. The results of this study suggest that modifying cheese manufacture protocols may have a direct impact on the bioactive properties of sweet whey. Future work will be required to identify and evaluate the feasibility to purify bioactive peptides obtained from sweet whey.

Type
Research Article
Copyright
Copyright © The Author(s), 2020. Published by Cambridge University Press on behalf of Hannah Dairy Research Foundation

Worldwide estimations indicate that cheese production has experienced an increase of more than 22% during the period 2005–2014, reaching production levels of more than 21 million tonnes per annum (FAO, 2020). A similar increase in cheese production rate has also been observed in Chile, which is focused for both internal and export markets within Latin America, mainly based on the manufacture of three varieties: fresh, Chanco and Gouda-style (Oliveira and Brito, Reference Oliveira, Brito and Tamine2006). Fresh cheese consists of a rennet coagulated variety made from pasteurized milk, with no starter cultures added and high moisture content that is usually consumed within 10 d after manufacture (Guzman and Ilabaca, Reference Guzman and Ilabaca2007). Chanco cheese has a semi-soft texture and buttery flavours and is made from rennet coagulation of pasteurized milk, with starter cultures added and ripened for 2 to 6 weeks (Vyhmeister et al., Reference Vyhmeister, Geldsetzer-Mendoza, Medel-Marabolí, Fellenberg, Vargas-Bello-Pérez and Ibáñez2019). Latin American countries and the United States produce a block Gouda-style cheese made from pasteurized milk, starter cultures, direct or brined salting and ripening times that ranges from 2 weeks up to 6 months (Oliveira and Brito, Reference Oliveira, Brito and Tamine2006; Ibáñez et al., Reference Ibáñez, Govindasamy-Lucey, Jaeggi, Johnson, McSweeney and Lucey2020). The application of whey dilution (WD; partial removal of whey during manufacture, along with replacement of that volume with water generally ranging from 15 to 45%) is extensively used in the manufacture of Chanco and Gouda cheeses to control acid development (Vyhmeister et al., Reference Vyhmeister, Geldsetzer-Mendoza, Medel-Marabolí, Fellenberg, Vargas-Bello-Pérez and Ibáñez2019; Ibáñez et al., Reference Ibáñez, Govindasamy-Lucey, Jaeggi, Johnson, McSweeney and Lucey2020). However, one of the disadvantages of this technique is associated with a considerable increase in the volume of sweet whey (i.e., liquid by-product obtained from cheese manufacture; SW) that will have to be further processed. The generation of SW obtained from the cheese industry in the Chilean market (considering ~4 kg/kg cheese in fresh cheese, and ~9 kg/kg cheese in Chanco and Gouda varieties with no WD; Oliveira and Brito, Reference Oliveira, Brito and Tamine2006) exceeds 1.5 million metric tonnes per annum and it is estimated that less than 50% of this volume is processed into dried commodity products for feed and food industry, therefore, potential alternative uses have to be explored. In recent years SW components have shown bioactive properties that are potentially beneficial for human health (Yadav et al., Reference Yadav, Yan, Pilli, Kumar, Tyagi and Surampalli2015). Different peptide fractions obtained from fresh cheese SW have shown antihypertensive properties when studied under in vitro conditions (i.e., inhibitory angiotensin converting enzyme activity; ACE-I; Tarango-Hernández et al., Reference Tarango-Hernández, Alarcón-Rojo, Robles-Sánchez, Gutiérrez-Méndez and Rodríguez-Figueroa2015) and may potentially be used as ingredients. We hypothesize that modifications to cheese making conditions, such as the application of WD, lead to changes in the composition of SW affecting their in vitro antihypertensive properties. Therefore, the objective of this study was to characterize the composition and ACE-I properties of SW obtained from model cheese manufacture methods using bulk tank milk from a dairy farm at different timepoints of a year.

Materials and methods

This study was conducted at the experimental dairy unit from the Pontifical Catholic University of Chile (Pirque, Chile) from January to November 2018. The cattle were comprised by approximately 240 Holstein cows in milk, producing in average 35 l/d/cow. Forty litres of raw milk were obtained directly from the bulk-tank at 4°C, 2 h after morning milking (5:00 AM) at six different timepoints: January, March (summer), May (autumn), July (winter), September and November (spring), 2018. Details of cattle in terms of number of lactating cows, lactation and climate conditions of location of study are shown in Supplementary Table S1. Milk samples were transported to the Department of Animal Science (Pontifical Catholic University of Chile) for further analyses and processing. Milks were standardized to a fat content of 3.5 g/100 g, transferred into individual 200 ml containers, pasteurized at 65°C × 30 min, cooled down and stored overnight at 4°C. The following morning, milk samples were heated at 31°C and used to make model cheeses on a miniature scale (200 g), according to the protocol described by Shakeel-Ur-Rehman et al. (Reference Shakeel-Ur-Rehman, McSweeney and Fox1998) with their respective modifications for fresh (Guzman and Ilabaca, Reference Guzman and Ilabaca2007), Chanco (Vyhmeister et al., Reference Vyhmeister, Geldsetzer-Mendoza, Medel-Marabolí, Fellenberg, Vargas-Bello-Pérez and Ibáñez2019) and Gouda-style varieties (Ibáñez et al., Reference Ibáñez, Govindasamy-Lucey, Jaeggi, Johnson, McSweeney and Lucey2020). Details of processing conditions are included in Supplementary Table S2, in which Chanco and Gouda-style varieties were also manufactured using WD at levels 0, 15, 30 or 45%.

Milk and SW obtained from cheesemaking were analysed for chemical composition [total solids (TS; gravimetric method), fat (Gerber method), total protein (N × 6.38; Kjeldahl method), ash (gravimetric method) and lactose (weight difference method)], titratable acidity, pH and protein profile by reversed phased-high performance liquid chromatography (RP-HPLC), as previously described (Ibáñez et al., Reference Ibáñez, Vyhmeister, Muñoz, Brossard, Osorio, Salazar and Vargas-Bello-Pérez2019). In addition, the in vitro ACE-I activity of SW samples was analysed according the spectrophotometric method described by Lu et al. (Reference Lu, Govindasamy-Lucey and Lucey2016). Each cheesemaking process was made in triplicate within 2 weeks for each experimental period. Since SW from fresh cheese was obtained with no WD, one-way analysis of variance (ANOVA) was performed to evaluate the effect of period on the chemical properties (P < 0.05). In contrast, SW from Chanco and Gouda-style cheese making were studied based on a 6 × 4 full factorial design using a general linear model to evaluate effects of period (January, March, May, July, September and November), levels of WD (0, 15, 30 and 45%) and their interactions on the composition and ACE-I properties. When significant differences were found (P < 0.05), means were analysed by Tukey's multiple comparison test. All analyses were performed using Minitab® 19 (Minitab Inc., State College, PA, USA).

Results

The standardized milks used to make model cheeses had no significant differences (P > 0.05) on their composition at different timepoints (Supplementary Table S3), including the protein-to-fat and lactose-to-protein ratios. The composition, pH and titratable acidity of model SW samples obtained from various cheese making protocols is presented in Table 1 and showed a great variability among varieties. Levels of TS in SW obtained from fresh cheese were in the range of 5.8–6.2 g/100 g, whereas those levels in treatments obtained from Chanco and Gouda-style cheese making (with no WD) were among 6.1–6.3 and 5.7–6.3 g/100 g, respectively. An increase in the level of WD during cheese manufacture led to SW with decreased levels of total solids, ash, titratable acidity and, as expected, increased pH values (P < 0.05). In contrast, the content of total protein remained constant when level of WD increased. This is also in accordance with the content of major whey proteins analysed by RP-HPLC (Supplementary Table S4), in which β-lactoglobulin (β -lac), α-lactalbumin (α-lac) and bovine serum albumin (BSA) accounted for ~50% of total proteins. Nevertheless, chromatograms from protein analysis of SW (Supplementary Fig. S1) also showed the presence of other unidentified peaks. Independently of the cheese variety and/or level of WD, the composition of SW was not greatly affected when obtained from different times of the year (P > 0.05).

Table 1. Composition and pH values of sweet whey obtained from the manufacture of fresh cheese with no WD, and Chanco and Gouda cheeses with different levels of whey dilution

Values represent mean and standard error of the mean (SEM; n = 3).

Levels of total solids (gravimetric method), total protein (N × 6.38), ash (gravimetric method), lactic acid (titratable acidity method) and pH were measured as described by Ibáñez et al. (Reference Ibáñez, Vyhmeister, Muñoz, Brossard, Osorio, Salazar and Vargas-Bello-Pérez2019).

abcMeans within the same row not sharing a common uppercase superscript differ (P < 0.05), comparing the effect of timepoint period.

ABCMeans within the same column (for a particular parameter) not sharing a common uppercase superscript differ (P < 0.05), comparing the effect of whey dilution at a single treatment.

Experimental SW exhibited an in-vitro capacity on inhibiting ACE among 55 and 95% (results not shown). To reduce the variability of ACE-I values in SW samples, these results were expressed as the concentration of protein required to inhibit the ACE to 50% their original activity (i.e., IC50 values; Fig. 1). SW from fresh, Chanco and Gouda-style cheeses showed no significant differences (P > 0.05) in the IC50 values throughout the year. The IC50 values found in SW from fresh cheese (Fig. 1a) ranged among 4.8 and 6.3 mg/ml. In contrast, increasing levels of WD during cheese manufacture (from 0 to 45%) led to SW with a significant (P < 0.05) reduction of IC50 values (i.e., improvement of ACE-I activity) from 5.0–5.8 to 3.1–4.3 mg/ml (Chanco; Fig. 1b) and 4.6–5.2 to 3.1–3.8 mg/ml (Gouda-style; Fig. 1c).

Fig. 1. Experimental IC50 values (i.e., concentration required to inhibit ACE to 50% of its original activity) of sweet whey obtained from the manufacture of fresh (a), Chanco (b) and Gouda-style cheeses (c) using 0 (■), 15 (//), 30 Indicator of bar for 30% should be colored grey and NOT BLACK (0% treatment) and 45% (□) of whey dilution and obtained at different timepoints. Values represent mean and standard deviation (n = 3).

Discussion

Similarities in the composition of model SW samples obtained at different timepoints of the year could be mainly attributed to similar composition of standardized milks (Supplementary Table S3), as well as the application of standard cheesemaking protocols based on milk composition and rate of acidification (Supplementary Table S2). Lactation stage greatly affects bovine milk composition, such as a reduced protein and fat content, along with increased lactose content in mid lactation milks, as compared with milk obtained from late lactation (Hinz et al., Reference Hinz, O'Connor, O'Brien, Huppertz, Ross and Kelly2012). However, the cattle used for our study did not show a marked trend on a particular lactation stage (Supplementary Table S1), maintaining similar lactose-to-protein ratio throughout the year (Supplementary Table S3), along with standardization of fat content. In a standardized cheese making process, the addition of calcium chloride and rennet are based on the concentration of protein, along with controlling acid development (i.e., changes of pH) at critical steps during processing (Vyhmeister et al., Reference Vyhmeister, Geldsetzer-Mendoza, Medel-Marabolí, Fellenberg, Vargas-Bello-Pérez and Ibáñez2019; Ibáñez et al., Reference Ibáñez, Govindasamy-Lucey, Jaeggi, Johnson, McSweeney and Lucey2020), which reduce variability of cheese and SW composition. The use of WD aims to reduce acid development in cheeses (Ibáñez et al., Reference Ibáñez, Govindasamy-Lucey, Jaeggi, Johnson, McSweeney and Lucey2020), including those varieties produced and consumed in Latin America (Chanco and Gouda-style; Oliveira and Brito, Reference Oliveira, Brito and Tamine2006). As expected, increasing levels of WD (due to the addition of water to levels of up to 45% of the mixture curd-whey and/or the application of a second dilution performed during the manufacture of Gouda cheeses; Supplementary Table S2) removes more lactose (and/or lactic acid) from the curd, but also leads to SW with reduced levels of TS. However, one of the major disadvantages associated with increased levels of WD, from a sustainability point of view, is the use of more energy required to remove water (Ibáñez et al., Reference Ibáñez, Govindasamy-Lucey, Jaeggi, Johnson, McSweeney and Lucey2020). Levels of major whey proteins found in SW samples are in accordance with those reported by the literature, since levels of β-lac, α-lac and BSA account for 45–55% of total protein fractions from SW (Yadav et al., Reference Yadav, Yan, Pilli, Kumar, Tyagi and Surampalli2015). The presence of other unidentified peak fractions in RP-HPLC chromatograms (Supplementary Fig. S1) could be associated with other minor proteins, as well as peptides released during cheesemaking, such as the glycomacropeptide (GMP) fraction derived from κ-casein that accounts up to 20% of total protein fraction from SW (Yadav et al., Reference Yadav, Yan, Pilli, Kumar, Tyagi and Surampalli2015).

The ACE-I properties of SW samples obtained from various cheese varieties using different levels of WD are in accordance with Miguel et al. (Reference Miguel, Contreras, Recio and Aleixandre2009), who found that the IC50 values from unhydrolysed milk proteins were ≥ 1 mg/ml and, when hydrolysed, they could be significantly improved. Tarango-Hernández et al. (Reference Tarango-Hernández, Alarcón-Rojo, Robles-Sánchez, Gutiérrez-Méndez and Rodríguez-Figueroa2015) found that low-molecular fractions (<5 kDa) obtained from different fresh-style cheeses SW exhibited the highest ACE-I activities when compared to other major fractions and were probably attributed to the presence of sequences peptides generated during cheese manufacture. In our study, we believe that an increase of ACE-I activity (i.e., reduced IC50 values) in Chanco and Gouda-style SW samples using higher proportions of WD could be associated with an increase in the production of low molecular weight water-soluble ACE-I casein-derived peptides, which is probably explained due to the capacity of chymosin for hydrolysing other individual caseins (α s-, β-), the activity of starter cultures enzymes (Uniacke-Lowe and Fox, Reference Uniacke-Lowe, Fox, McSweeney, Fox, Cotter and Everett2017) and extended cheese making times required to acidify the whey/curd mixture before whey drainage, due to the addition of water for dilution, which may have allowed more enzymatic hydrolysis.

No major changes in the composition of model SW samples were found when milks supplied at different times of the year had similar composition, in addition with the application of standardized cheese making protocols. However, modification of cheese manufacture protocols (such as the application of various WD levels) may lead to differences in the composition and ACE-I properties of model SW. One of the many applications of SW could be associated with the purification of low-molecular compounds with bioactive properties generated from cheese manufacture that could be potentially used as ingredients. However, future work will be required to evaluate its feasibility.

In conclusion, the use of whey dilution led to sweet whey samples with reduced levels of total solids but improved in vitro antihypertensive properties, which may be attributed to the formation of low-molecular weight bioactive peptides due to increased cheese making times. Further work will be required to identify and evaluate the feasibility to purify bioactive peptides obtained from sweet whey.

Supplementary material

The supplementary material for this article can be found at https://doi.org/10.1017/S0022029920001041.

Acknowledgements

This study was supported by Vicerrectoría Académica, Programa de Inserción Académica (Pontificia Universidad Católica de Chile) and Programa Tecnológico de Ingredientes Funcionales y Aditivos Naturales Especializados (Chile; IFAN 16PTECAI-66648-P16).

References

FAO (2020) Food and Agriculture Organization corporate statistical database. Available at http://www.fao.org/faostat/en/#home (Accessed April 4, 2020).Google Scholar
Guzman, V and Ilabaca, C (2007) Utilizacion de leche de vaca, cabra y oveja en la pequena empresa [Use of cow, goat and sheep milk in small dairy industry], Santiago, Chile: Fundacion para la Innovacion Agraria, ChileGoogle Scholar
Hinz, K, O'Connor, PM, O'Brien, B, Huppertz, T, Ross, RP and Kelly, AL (2012) Proteomic study of proteolysis during ripening of Cheddar cheese made from milk over a lactation cycle. Journal of Dairy Research 79, 176184.CrossRefGoogle Scholar
Ibáñez, RA, Vyhmeister, S, Muñoz, MF, Brossard, N, Osorio, F, Salazar, FN and Vargas-Bello-Pérez, E (2019) Influence of milk pH on the chemical, physical and sensory properties of a milk-based alcoholic beverage. Journal of Dairy Research 86, 248251.CrossRefGoogle ScholarPubMed
Ibáñez, RA, Govindasamy-Lucey, S, Jaeggi, JJ, Johnson, ME, McSweeney, PLH and Lucey, JA (2020) Low and reduced fat milled curd, direct-salted Gouda cheese: comparison of lactose standardization of cheese milk and whey dilution techniques. Journal of Dairy Science 103, 11751192.CrossRefGoogle ScholarPubMed
Lu, Y, Govindasamy-Lucey, S and Lucey, JA (2016) Angiotensin-I-converting enzyme-inhibitory peptides in commercial Wisconsin Cheddar cheeses of different ages. Journal of Dairy Science 99, 4152.CrossRefGoogle ScholarPubMed
Miguel, M, Contreras, MM, Recio, I and Aleixandre, A (2009) ACE-inhibitory and antihypertensive properties of a bovine casein hydrolysate. Food Chemistry 112, 211214.CrossRefGoogle Scholar
Oliveira, MN and Brito, C (2006) Brined cheeses and analogues from Latin American origin. In Tamine, A (ed), Brined Cheeses, Oxford, UK: Blackwell Publishing Ltd., pp. 211248CrossRefGoogle Scholar
Shakeel-Ur-Rehman, , McSweeney, PLH and Fox, PF (1998) Protocol for the manufacture of miniature cheeses. Lait, 78, 607620CrossRefGoogle Scholar
Tarango-Hernández, S, Alarcón-Rojo, AD, Robles-Sánchez, M, Gutiérrez-Méndez, N and Rodríguez-Figueroa, JC (2015) Short communication: potential of fresco-style cheese whey as a source of protein fractions with antioxidant and angiotensin-I-converting enzyme inhibitory activities. Journal of Dairy Science 98, 76357639.CrossRefGoogle ScholarPubMed
Uniacke-Lowe, T and Fox, PF (2017) Chymosin, pepsins and other aspartyl proteinases: structures, functions, catalytic mechanism and milk-clotting properties. In McSweeney, PLH, Fox, PF, Cotter, PD and Everett, DW (eds), Cheese: Chemistry, Physics and Microbiology, vol. 1, London, UK: Academic Press, pp. 69113CrossRefGoogle Scholar
Vyhmeister, S, Geldsetzer-Mendoza, C, Medel-Marabolí, M, Fellenberg, A, Vargas-Bello-Pérez, E and Ibáñez, RA (2019) Influence of using different proportions of cow and goat milk on the chemical, textural and sensory properties of Chanco–style cheese with equal composition. LWT 112, 108226.CrossRefGoogle Scholar
Yadav, JSS, Yan, S, Pilli, S, Kumar, L, Tyagi, RD and Surampalli, RY (2015) Cheese whey: a potential resource to transform into bioprotein, functional/nutritional proteins and bioactive peptides. Biotechnology Advances 33, 756774.CrossRefGoogle ScholarPubMed
Figure 0

Table 1. Composition and pH values of sweet whey obtained from the manufacture of fresh cheese with no WD, and Chanco and Gouda cheeses with different levels of whey dilution

Figure 1

Fig. 1. Experimental IC50 values (i.e., concentration required to inhibit ACE to 50% of its original activity) of sweet whey obtained from the manufacture of fresh (a), Chanco (b) and Gouda-style cheeses (c) using 0 (■), 15 (//), 30 Indicator of bar for 30% should be colored grey and NOT BLACK (0% treatment) and 45% (□) of whey dilution and obtained at different timepoints. Values represent mean and standard deviation (n = 3).

Supplementary material: PDF

Godoy et al. supplementary material

Godoy et al. supplementary material

Download Godoy et al. supplementary material(PDF)
PDF 361.4 KB